Rigor Reviewed

Rigor-Reviewed Manuscript

Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial.

Name: Αlpha¹ Rigor Record — Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial.
Item: Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial.
Rating: 59
Author: Αlpha¹

Temba GS, Pecht T, Kullaya VI, Vadaq N, Mosha MV, Ulas T, Kanungo S, van Emst L, Bonaguro L, Schulte-Schrepping J, Mafuru E, Lionetti P, Mhlanga MM, van der Ven AJ, Cavalieri D, Joosten LAB, Kavishe RA, Mmbaga BT, Schultze JL, Netea MG, de Mast Q

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 1.5★ (Critical), 0 critical, 4 high issues for “Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

1.5 / 5

Critical — serious problems across many checks

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×4−2★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingStudy design partially met−0.25★
ReportingEthical approvals partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

Statistics were not checked: no recomputable values were found in this text — no test statistic reported with its degrees of freedom, no effect estimate printed with both a 95% CI and a p-value, and no percentage printed with both its count and its denominator.

Problems surfaced6 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions3

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Treatment effect not shown to be clinically meaningfulAssessed
Conclusions only partially backed by the presented evidenceAssessed

Reporting gaps2

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Ethics/consent reporting incompleteAssessed
Study-design details incomplete (controls, blinding, power)Assessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

The paper is a well-conducted open-label randomized controlled crossover trial with strong data and code availability, thorough statistical methods, and transparent reporting. The main weaknesses are missing details on randomization method, blinding rationale, power analysis, and explicit ethics approval and informed consent statements.

Both reviewers classified the study as interventional, and this was adopted. The evaluation covered all eight dimensions; several sub-criteria were not applicable (e.g., animal-related items). The reviewers agreed on all dimension statuses, so no divergence needed reconciliation.

4 major claims checked against the paper's own evidence: 1 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: surrogate not validated for clinical benefit; effect size not shown to be clinically meaningful.

4 integrity concerns flagged (0 high).

Reporting

Eight Dimensions6 pass · 2 warn

The introduction cites prior cross-sectional studies and literature on Western diets, heritage diets, and fermented foods, acknowledging limitations of cross-sectional designs. The rationale for the RCT is clearly stated, and the study objectives follow logically from the cited evidence. Limitations of prior research are addressed by the choice of an interventional design.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise with extensive prior work and a logical rationale linking dietary transitions to immune and metabolic effects.

Evidence

paraphrase[Introduction, paragraph 3]

“Cross-sectional observational studies are limited in establishing causal relationships and controlling confounders. Therefore, we performed an open-label, randomized controlled trial...”

direct quote[Introduction, paragraph 3]

“The study investigated the effects of switching from a Western-style diet to a Kilimanjaro heritage diet and vice versa, and the effects of consuming the fermented beverage ‘Mbege’.”